Somaxon (Nasdaq: SOMX) reports a Q1 loss of $0.39, 3 cents worse than the analyst estimate of ($0.36).

As ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE